CompuGroup Medical SE & Co. KGaA (ETR:COP)
Germany
· Delayed Price · Currency is EUR 22.62
-0.08 (-0.35%)
Mar 31, 2025, 1:38 PM CET
ETR:COP Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 1,186 | 1,228 | 1,175 | 1,063 | 869.13 | Upgrade
|
| Other Revenue | 0.6 | 0.11 | 0.25 | 0.08 | 0.08 | Upgrade
|
| Revenue | 1,186 | 1,228 | 1,175 | 1,063 | 869.21 | Upgrade
|
| Revenue Growth (YoY) | -3.39% | 4.52% | 10.55% | 22.26% | 12.82% | Upgrade
|
| Cost of Revenue | 784.28 | 813.16 | 763.1 | 689.15 | 533.23 | Upgrade
|
| Gross Profit | 402.03 | 414.75 | 411.71 | 373.55 | 335.98 | Upgrade
|
| Selling, General & Admin | 12.01 | 11.85 | 11.63 | 10.78 | 8.82 | Upgrade
|
| Other Operating Expenses | 172.24 | 164.46 | 179.32 | 144.21 | 126.97 | Upgrade
|
| Operating Expenses | 304.11 | 292.09 | 313.14 | 266.92 | 215.79 | Upgrade
|
| Operating Income | 97.92 | 122.66 | 98.56 | 106.63 | 120.19 | Upgrade
|
| Interest Expense | -31.43 | -24.32 | -9.12 | -5.4 | -5.3 | Upgrade
|
| Interest & Investment Income | 1.32 | 1.06 | 0.81 | 0.72 | 1.52 | Upgrade
|
| Earnings From Equity Investments | -0.8 | 0.62 | -0.1 | 0.03 | -0.93 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.02 | -2.94 | 1.08 | -0.39 | -4.27 | Upgrade
|
| Other Non Operating Income (Expenses) | -10.18 | -15.18 | 17.27 | 0.74 | -0.92 | Upgrade
|
| EBT Excluding Unusual Items | 56.85 | 81.9 | 108.51 | 102.34 | 110.29 | Upgrade
|
| Gain (Loss) on Sale of Assets | 5.85 | 1.04 | 0.16 | 1.69 | 0.14 | Upgrade
|
| Asset Writedown | -1.87 | -11.45 | -0.34 | -6.15 | - | Upgrade
|
| Other Unusual Items | -3.53 | 0.64 | -1.51 | 0 | - | Upgrade
|
| Pretax Income | 61.89 | 72.67 | 106.82 | 97.87 | 110.43 | Upgrade
|
| Income Tax Expense | 27.13 | 25.8 | 32.7 | 28.84 | 37.01 | Upgrade
|
| Earnings From Continuing Operations | 34.76 | 46.87 | 74.12 | 69.03 | 73.42 | Upgrade
|
| Net Income to Company | 34.76 | 46.87 | 74.12 | 69.03 | 73.42 | Upgrade
|
| Minority Interest in Earnings | -0.16 | -0.96 | -0.71 | -0.06 | -0.23 | Upgrade
|
| Net Income | 34.6 | 45.92 | 73.41 | 68.97 | 73.19 | Upgrade
|
| Net Income to Common | 34.6 | 45.92 | 73.41 | 68.97 | 73.19 | Upgrade
|
| Net Income Growth | -24.64% | -37.45% | 6.44% | -5.77% | 11.20% | Upgrade
|
| Shares Outstanding (Basic) | 52 | 52 | 52 | 53 | 51 | Upgrade
|
| Shares Outstanding (Diluted) | 53 | 52 | 52 | 53 | 52 | Upgrade
|
| Shares Change (YoY) | 0.63% | 0.32% | -1.29% | 1.15% | 5.96% | Upgrade
|
| EPS (Basic) | 0.67 | 0.88 | 1.41 | 1.30 | 1.43 | Upgrade
|
| EPS (Diluted) | 0.66 | 0.88 | 1.40 | 1.30 | 1.40 | Upgrade
|
| EPS Growth | -24.92% | -37.21% | 7.69% | -7.14% | 5.26% | Upgrade
|
| Free Cash Flow | 104.08 | 160.56 | 119.18 | 138.23 | 132.25 | Upgrade
|
| Free Cash Flow Per Share | 1.97 | 3.06 | 2.28 | 2.61 | 2.52 | Upgrade
|
| Dividend Per Share | 0.050 | 1.000 | 0.500 | 0.500 | 0.500 | Upgrade
|
| Dividend Growth | -95.00% | 100.00% | - | - | - | Upgrade
|
| Gross Margin | 33.89% | 33.78% | 35.05% | 35.15% | 38.65% | Upgrade
|
| Operating Margin | 8.25% | 9.99% | 8.39% | 10.03% | 13.83% | Upgrade
|
| Profit Margin | 2.92% | 3.74% | 6.25% | 6.49% | 8.42% | Upgrade
|
| Free Cash Flow Margin | 8.77% | 13.08% | 10.14% | 13.01% | 15.21% | Upgrade
|
| EBITDA | 146.86 | 169.81 | 151.77 | 160.91 | 158.65 | Upgrade
|
| EBITDA Margin | 12.38% | 13.83% | 12.92% | 15.14% | 18.25% | Upgrade
|
| D&A For EBITDA | 48.94 | 47.15 | 53.2 | 54.28 | 38.46 | Upgrade
|
| EBIT | 97.92 | 122.66 | 98.56 | 106.63 | 120.19 | Upgrade
|
| EBIT Margin | 8.25% | 9.99% | 8.39% | 10.03% | 13.83% | Upgrade
|
| Effective Tax Rate | 43.84% | 35.50% | 30.61% | 29.47% | 33.51% | Upgrade
|
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.